Medtronic (MDT) closed the most recent trading day at $78.3, moving 2.13% from the previous trading session.
Atrioventricular Interval Modulation (“AVIM”) Therapy Food and Drug Administration (“FDA”) Breakthrough Device Designations span the broader population of patients with uncontrolled hypertensi
In the closing of the recent trading day, Medtronic (MDT) stood at $81.9, denoting a -1.23% move from the preceding trading day.
Following recent FDA clearances, Medtronic is accelerating access to integrated planning, navigation, and robotics platform across Europe GALWAY, Ireland, April 28, 2026 /PRNewswire/ -- Medtronic, a
It may not seem like it at first, but these dividends are safe.
Medtronic is a diversified MedTech company undergoing business simplification and cost improvements, with a focus on margin recovery over high growth. MDT trades at a discount to peers, reflecting low
Medical device maker Medtronic said on Monday a cyberattack on its computer systems last week ​did not affect its products or ability ‌to meet patient needs, and is not expected to materially impa
Advisors Capital Management LLC grew its holdings in Medtronic PLC (NYSE: MDT) by 4.5% during the fourth quarter, according to its most recent filing with the Securities and Exchange Commission (SEC).
HRS late-breaking data: Interim results highlight six-month outcomes for patients treated with the Sphere-9 catheter for sustained monomorphic ventricular tachycardia (VT) Breakthrough device designat
Some shareholders are waiting for healthcare stocks to rebound. As they wait, some companies pay out dividends with meaningful yields that make that waiting easier.
The real brain computer interface opportunity isn't in the headlines. These 10 stocks are building the systems that make it possible.
Boston Trust Walden Corp decreased its stake in Medtronic PLC (NYSE: MDT) by 58.6% during the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission. The f
Arizona State Retirement System lessened its stake in Medtronic PLC (NYSE: MDT) by 3.4% during the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commiss
Medtronic plc remains a medical device stalwart with a robust product portfolio, but faces slow growth, high debt, and competitive pressures. I maintain a Hold rating due to a 2.76 PEG ratio, modest r
Caprock Group LLC grew its holdings in shares of Medtronic PLC (NYSE: MDT) by 16.0% in the undefined quarter, according to its most recent disclosure with the SEC. The fund owned 80,968 shares of the
Click to get the best stock tips daily for free!

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE